Ideas

July 29, 2017

Published by admin_auro at July 29, 2017

Categories

Molecular hydrogen therapy for Diabetic nephropathy (DN): Hydrogen-rich water increases Pyruvate kinase M2 (PKM2) expression, decreases toxic glucose metabolites, mitochondrial dysfunction and apoptosis, augments glycolytic flux and PGC-1α levels, improves metabolic abnormalities, albuminuria, glomerular pathology, and renal dysfunction and alleviates diabetic nephropathy via down regulation of its target gene, 29/July/2017, 10.27 pm

Introduction: What they say A study from the Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA shows that “Pyruvate kinase M2 activation may […]

July 29, 2017

Published by admin_auro at July 29, 2017

Categories

Molecular Hydrogen therapy for tuberculosis: Hydrogen-rich water deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 29/July/2017, 9.51 pm

Introduction: What they say: A study from the Singapore Immunology Network, Agency for Science, Technology and Research, Singapore; and Lee Kong Chian School of Medicine, Nanyang […]

July 28, 2017

Published by admin_auro at July 28, 2017

Categories

Cancer
Ideas

Natural product-derived Ptpn2 pathway blockade enhances the efficacy of Cancer immunotherapy: γ-Bisabolene, isolated from Cardamom, inhibits the expression of protein tyrosine phosphatase PTPN2, increases interferon-IFNγ signalling, augments antigen presentation and unfolding response, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target gene, 28/July/2017, 11.04 pm

Introduction:What they say: A recent study from Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA; Broad Institute of Harvard and Massachusetts Institute of […]

July 28, 2017

Published by admin_auro at July 28, 2017

Categories

Cancer
Ideas

Molecular therapy for glioblastoma: MiRNA-766 inhibits the expression of JMJD6, impairs functioning of transcription elongation machinery, inhibits the proliferation of glioblastoma cells, suppresses tumor cell migration, reduces metastasis and prolongs survival via down regulation of its target gene, 28/July/2017, 10.57 pm

Introduction: What they say: A study from the Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Ohio, USA shows that “Transcription elongation factors represent in vivo […]